Why NRX Pharmaceuticals Stock Is Surging Today
NRX Pharmaceuticals Inc (NASDAQ: NRXP) is trading significantly higher Thursday after the company announced the Journal of Infectious Diseases and Treatment published trial data of aviptadil in high comorbidity patients suffering from critical COVID-19 with respiratory failure.
